Real‐world outcomes among patients with advanced or metastatic biliary tract cancers initiating second‐line treatment

BACKGROUND: Limited data are available regarding second‐line (2 L) treatment for advanced or metastatic biliary tract cancers (BTC) in the US real‐world setting. This study explores the rapidly evolving and growing treatment landscape in the 2 L setting for advanced or metastatic BTC with a large co...

Descripción completa

Detalles Bibliográficos
Autores principales: Cosgrove, David P., Reese, Emily S., Fulcher, Nicole M., Bobiak, Sarah S., Lamy, Francois‐Xavier, Allignol, Arthur, Boyd, Marley, Mahmoudpour, Seyed H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
RESEARCH ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9972013/
https://www.ncbi.nlm.nih.gov/pubmed/36263922
http://dx.doi.org/10.1002/cam4.5282

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9972013/
https://www.ncbi.nlm.nih.gov/pubmed/36263922
http://dx.doi.org/10.1002/cam4.5282

Ejemplares similares